208 related articles for article (PubMed ID: 7515993)
1. Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia.
Nakae I; Quan L; Sugimoto Y; Tsutamoto T; Kinoshita M
J Cardiovasc Pharmacol; 1994 Mar; 23(3):473-9. PubMed ID: 7515993
[TBL] [Abstract][Full Text] [Related]
2. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.
Nakae I; Quan L; Hashimoto K; Sugimoto Y; Tsutamoto T; Kinoshita M
Cardiovasc Drugs Ther; 1994 Feb; 8(1):137-45. PubMed ID: 8086324
[TBL] [Abstract][Full Text] [Related]
4. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide.
Imagawa J; Akima M; Nabata H; Taira N
J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676
[TBL] [Abstract][Full Text] [Related]
5. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
Giudicelli JF; la Rochelle CD; Berdeaux A
J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761
[TBL] [Abstract][Full Text] [Related]
6. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels.
Auchampach JA; Cavero I; Gross GJ
J Cardiovasc Pharmacol; 1992; 20(5):765-71. PubMed ID: 1280739
[TBL] [Abstract][Full Text] [Related]
7. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
Cavero I; Pratz J; Mondot S
Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
[TBL] [Abstract][Full Text] [Related]
8. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
Satoh K; Yamada H; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
[TBL] [Abstract][Full Text] [Related]
9. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of action of KRN2391 in canine coronary vascular bed.
Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N
Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
[TBL] [Abstract][Full Text] [Related]
11. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil.
Yanagisawa T; Teshigawara T; Taira N
Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290
[TBL] [Abstract][Full Text] [Related]
13. Potassium channel openers dilate large epicardial coronary arteries in conscious dogs by an indirect, endothelium-dependent mechanism.
la Rochelle CD; Richard V; Dubois-Randé JL; Roupie E; Giudicelli JF; Hittinger L; Berdeaux A
J Pharmacol Exp Ther; 1992 Dec; 263(3):1091-6. PubMed ID: 1469622
[TBL] [Abstract][Full Text] [Related]
14. KATP channel activation mediates nicorandil-induced relaxation of nitrate-tolerant coronary arteries.
O'Rourke ST
J Cardiovasc Pharmacol; 1996 Jun; 27(6):831-7. PubMed ID: 8761850
[TBL] [Abstract][Full Text] [Related]
15. Nicorandil increases coronary blood flow predominantly by K-channel opening mechanism.
Yoneyama F; Satoh K; Taira N
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1119-26. PubMed ID: 2150593
[TBL] [Abstract][Full Text] [Related]
16. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
[TBL] [Abstract][Full Text] [Related]
17. Beta 2-adrenergic dilation of resistance coronary vessels involves KATP channels and nitric oxide in conscious dogs.
Ming Z; Parent R; Lavallée M
Circulation; 1997 Mar; 95(6):1568-76. PubMed ID: 9118527
[TBL] [Abstract][Full Text] [Related]
18. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in the vasorelaxing effect of nicorandil on dog epicardial coronary arteries: comparison with other NO donors.
Matsumoto T; Takahashi M; Omura T; Takaoka A; Liu Q; Nakae I; Kinoshita M
J Cardiovasc Pharmacol; 1997 Jun; 29(6):772-9. PubMed ID: 9234658
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of blockade of nitric oxide formation on resistance and conductance coronary vessels in conscious dogs.
Parent R; Hamdad N; Ming Z; Lavallée M
Cardiovasc Res; 1996 Apr; 31(4):555-67. PubMed ID: 8689647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
